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Most solid tumors are characterized by abnormal chromosome numbers (aneuploidy) and
karyotypic profiling has shown that the majority of these tumors are heterogeneous
and chromosomally unstable. Chromosomal instability (CIN) is defined as persistent mis-
segregation of whole chromosomes and is caused by defects during mitosis. Large-scale
genome sequencing has failed to reveal frequent mutations of genes encoding proteins
involved in mitosis. On the contrary, sequencing has revealed that most mutated genes in
cancer fall into a limited number of core oncogenic signaling pathways that regulate the
cell cycle, cell growth, and apoptosis.This led to the notion that the induction of oncogenic
signaling is a separate event from the loss of mitotic fidelity, but a growing body of evi-
dence suggests that oncogenic signaling can deregulate cell cycle progression, growth,
and differentiation as well as cause CIN. These new results indicate that the induction of
CIN can no longer be considered separately from the cancer-associated driver mutations.
Here we review the primary causes of CIN in mitosis and discuss how the oncogenic
activation of key signal transduction pathways contributes to the induction of CIN.
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cancer, genomic instability
ANEUPLOIDY AND CIN IN TUMORS
Most solid tumors have abnormal chromosome numbers (aneu-
ploidy) and large-scale structural genomic rearrangements (Hana-
han and Weinberg, 2000, 2011). Karyotypic analyses show that
tumors display both intra- and inter-tumor heterogeneity sug-
gesting that most tumors are not only aneuploid, but also chromo-
somally unstable. Chromosomal instability (CIN) is defined as a
persistent high rate of gain/loss of whole chromosomes (Lengauer
et al., 1997). CIN is present in most aneuploid solid tumors and
is an important hallmark of genome instability associated with
cancer. Since CIN (and the consequent aneuploidy) is caused by
aberrant chromosome segregation, it is probable that most cancer
cells acquire defects in the machinery responsible for faithful chro-
mosome segregation in mitosis. These defects could arise through
either mutation of genes encoding essential mitotic proteins or by
imbalances in protein levels or activities that reduce mitotic fidelity
(reviewed in Schvartzman et al., 2010; Nicholson and Cimini,
2011).
Aneuploidy and CIN commonly go hand-in-hand because the
proximal outcome of CIN is to create deviations in the karyotype.
However, it is important to note that aneuploidy and CIN are
distinct (Thompson and Compton, 2008). Aneuploidy is a state
of abnormal chromosome number and some tumors have abnor-
mal, yet stable karyotypes (i.e., all the cells in the tumor have
the same defective karyotype). CIN is a high rate of chromo-
some mis-segregation that enhances karyotypic diversity in cells
within the same tumor, a feature commonly associated to tumor
aggressiveness (Storchova and Pellman, 2004; Geigl et al., 2008).
On average, CIN cancer cells mis-segregate a chromosome once
in every one to five cell divisions (Lengauer et al., 1997; Thomp-
son and Compton, 2008), an event which is thought to drive the
genomic re-shuffling that allows cells to acquire new phenotypes
such as drug resistance. Significantly, both aneuploidy and CIN
have been associated with poor patient prognosis, metastasis, and
resistance to chemotherapeutics (Kuukasjarvi et al., 1997; Carter
et al., 2006; Walther et al., 2008; Swanton et al., 2009; Bakhoum
et al., 2011; Lee et al., 2011; Smid et al., 2011; McGranahan et al.,
2012) and recent reports have shown that aneuploidy and CIN
play a causal role in tumorigenesis and relapse (Weaver et al.,
2007; Baker et al., 2009; Sotillo et al., 2010). Thus, understand-
ing the mechanisms that cause CIN offers an attractive possibility
to intervene in tumor aggressiveness and enhance the efficiency of
cancer therapy.
Large-scale genome sequencing has revealed the most com-
monly mutated genes in cancer (Cancer Genome Atlas Research
Network, 2008, 2011, 2012; Jones et al., 2008). These cancer-
causing genes encode proteins responsible for cell cycle control
and cell signaling pathways responsible for cell growth and death.
Genome sequencing analyses have revealed very few mutations in
genes that encode proteins involved in chromosome segregation
during mitosis. Thus, the persistent mis-segregation of chromo-
somes in CIN tumor cells has been largely attributed to errors
arising during mitosis that were not directly linked to the driver
mutations in oncogenic signaling pathways. However, the idea that
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CIN is caused by events that are independent of the oncogenic sig-
naling pathways is beginning to falter. Emerging data show that
CIN and the oncogenic signaling pathways responsible for dri-
ving tumor formation are closely interrelated. Here we provide a
brief overview of the mitotic defects that commonly cause CIN and
then explain how oncogenic signaling pathways that are commonly
de-regulated in cancer influence mitosis to induce CIN.
CAUSES OF CIN IN CANCER CELLS
The persistently high rate of chromosome mis-segregation associ-
ated with CIN in tumor cells has been attributed to four primary
defects in mitosis (Figure 1, inner circle). The first mitotic defect
proposed to cause CIN was an impaired spindle assembly check-
point (SAC). This idea stemmed from a study demonstrating
that CIN is caused by mutational inactivation of the essential
SAC component Bub1 (Cahill et al., 1998). Although the initial
identification of mutations in Bub1 was encouraging, subsequent
genome sequencing showed that mutational inactivation of SAC
components is quite rare (Barber et al., 2008). Moreover, com-
plete loss of SAC function is lethal (reviewed in Kops et al., 2004;
Kops et al., 2005). Also, follow up experiments demonstrated that
most aneuploid cancer cells possess a functional SAC (Tighe et al.,
2001; Gascoigne and Taylor, 2008). These results gave rise to the
alternative hypothesis that partial loss of SAC function is respon-
sible for causing CIN. Evidence in favor of this view is derived
from the high incidence of aneuploidy and tumorigenesis in mice
engineered to have weakened SAC activity (Michel et al., 2001;
Dai et al., 2004). Moreover, in humans, reduced SAC activity has
been observed in individuals with Mosaic Variegated Aneuploidy
(MVA), an extremely rare disease strongly linked to mutations in
SAC component BubR1 (Hanks et al., 2004; Suijkerbuijk et al.,
2010).
The second mitotic defect shown to cause CIN is the persis-
tence of errors in kinetochore-microtubule (k-MT) attachments
FIGURE 1 | Schematic representation of the downstream targets of
oncogenic signaling pathways that affect mitotic fidelity. The inner circle
represents chromosomal instability (CIN) and the middle circle is composed
of the four primary defects in mitosis known to cause CIN. The downstream
targets of oncogenic pathways involved in the four primary CIN-causing
mitotic defects comprise the outer circle. Note that some downstream
targets (e.g., APC) have been demonstrated to play a role in more than one
CIN-causing mitotic defect.
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as revealed by live imaging of cancer cells (Thompson and Comp-
ton, 2008; Compton, 2011). Faithful chromosome segregation
relies on the bi-oriented attachment of chromosomes to spindle
microtubules. Kinetochores in human cells bind approximately 25
microtubules and errors in the orientation of k-MT attachments
arise through the stochastic nature of interactions between micro-
tubules and kinetochores. Merotely is a specific k-MT attachment
error defined by single kinetochores that simultaneously attach
microtubules oriented toward both spindle poles. Merotely avoids
detection by the SAC since kinetochores attain full occupancy
of microtubules (albeit with improper orientation). Thus, if cells
enter anaphase with merotelically attached kinetochores, the chro-
matid attached to both spindle poles will fail to segregate properly
and lag near the central spindle as other chromosomes move pole-
ward. This can cause chromosome mis-segregation and lagging
chromosomes in anaphase were the most common defect in mito-
sis observed by live cell imaging in cancer cell lines. Error-free
mitosis is promoted by microtubule detachment from kineto-
chores and the stability of k-MT attachments is regulated through
the concerted action of several mitotic kinases, notably Aurora B
(Lampson et al., 2004; Pinsky et al., 2006). Direct measurements
show that many CIN cancer cells have hyperstable k-MT attach-
ments which undermines their ability to correct errors and leads to
high rates of chromosome mis-segregation. Importantly, increas-
ing the detachment rate of k-MT improves error correction and is
sufficient to restore faithful chromosome segregation in CIN can-
cer cells (Bakhoum et al., 2009a,b; Kabeche and Compton, 2012).
These results are the first genetic demonstration of the correction
of CIN and provide direct causal evidence that impaired regula-
tion of k-MT attachments is an underlying cause of CIN in human
cancer cells.
The third mitotic defect leading to CIN is the presence of
supernumerary centrosomes. Centrosome duplication is tightly
regulated during the cell cycle such that normal cells enter mitosis
with only two. Two centrosomes foster bipolar spindle formation,
yet it has been well documented that cancer cells frequently enter
mitosis with more than two centrosomes leading to multipolar
spindles (reviewed in Nigg, 2002; Fukasawa, 2005; Bakhoum and
Compton, 2009; Anderhub et al., 2012; Vitre and Cleveland, 2012).
Interestingly, the frequency of multipolar spindles is higher in
prometaphase than in anaphase indicating that centrosomes clus-
ter to promote bipolar spindle formation prior to anaphase onset
(Brinkley, 2001; Quintyne et al., 2005; Basto et al., 2008). Despite
these centrosome clustering mechanisms, the presence of extra
centrosomes prolongs mitosis by delaying satisfaction of the SAC
even in cells with bipolar spindles (Yang et al., 2008) suggesting
that not all kinetochores are properly attached to microtubules. In
support of this, recent studies have shown that the transient mul-
tipolar spindles caused by supernumerary centrosomes increase
the propensity of merotelic k-MT attachments and elevate the
frequency of chromosome mis-segregation (Ganem et al., 2009;
Silkworth et al., 2009). Thus, extra centrosomes increase the rate
of formation of k-MT attachment errors leading to CIN.
The fourth mitotic defect causing CIN is tied to centromere
geometry. The integrity of centromeric structure ensures that
kinetochores are positioned in a back-to-back configuration. This
creates a geometric constraint that increases the probability that
sister kinetochores of a single chromosome will achieve proper
bi-orientated attachments to spindle microtubules (Indjeian and
Murray, 2007; Loncarek et al., 2007; Sakuno et al., 2009). It has
been shown that defects in pericentromeric cohesion undermine
the establishment of proper k-MT attachments (Ng et al., 2009).
The consequence is an increased rate of formation of k-MT
attachment defects that leads to elevated rates of chromosome
mis-segregation.
HOW ONCOGENIC PATHWAYS INDUCE CIN
A large fraction of tumors have driver mutations in genes encod-
ing components of a handful of conserved oncogenic pathways.
Although the specific genes that are mutated within each pathway
can differ between tumors from different individuals, the common
feature is that most tumors have mutations that cause aberrant
signaling in these key signal transduction pathways. For exam-
ple, sequencing analyses of pancreatic cancers and glioblastomas
revealed that a core set of 12 signaling pathways are genetically
altered in 67–100% of all tumors (Cancer Genome Atlas Research
Network, 2008; Jones et al., 2008). Here we discuss how the onco-
genic activation of these signaling pathways contributes to the
induction of CIN (Figure 1; Table 1).
THE RB PATHWAY
The retinoblastoma tumor suppressor protein (pRB) is a key reg-
ulator of the G1 to S transition during the cell cycle (Burkhart and
Sage, 2008). It was one of the first tumor suppressor genes identi-
fied and is commonly inactivated in several tumor types (Marshall,
1991). It is common for tumors with inactivating mutations in
pRB to be aneuploid with an increased susceptibility to changes
in DNA ploidy (Isaac et al., 2006; Mayhew et al., 2007; Srinivasan
et al., 2007; Amato et al., 2009a,b), and recent reports have shown
that pRB influences mitosis through a function that is independent
of its role in cell cycle progression (Sage and Straight, 2010). The
E2F transcription factor family proteins are downstream targets
that are negatively regulated by pRB. These transcription factors
regulate the expression of genes whose products are involved in
chromatin assembly/condensation, chromosome segregation, and
in the mitotic checkpoint such that loss of pRB increases their
transcription (Ren et al., 2002). For example, pRB negatively reg-
ulates the transcription of the gene encoding SAC protein Mad2
and loss of pRB signaling leads to overexpression of Mad2 giving
rise to aneuploidy and CIN (Hernando et al., 2004). A recent study
showed that Mad2 stabilizes k-MT attachment in a function that
is distinct from its role in the SAC (Kabeche and Compton, 2012).
Overexpression of Mad2 hyper-stabilizes k-MT attachments and
increases the rate of formation of k-MT attachment errors leading
to CIN.
Loss of pRB also alters chromatin structure. For example, pRB
has been shown to interact with the Condensin II complex and
participate in mitotic chromosome condensation. Loss of pRB
accelerates both loss of heterozygosity in the absence of p53 and
the rate of tumor formation (Coschi et al., 2010). Moreover, dis-
ruption of pRB in mice has been shown to disrupt pericentric
heterochromatin leading to centromere fusions, chromosome mis-
segregation, and consequently aneuploidy (Isaac et al., 2006). This
effect on centromere integrity was corroborated in a subsequent
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Table 1 |Table summarizing the CIN-causing mitotic phenotypes observed in different cell types and/or models upon de-regulated oncogenic
signaling.
Pathway Gene(s) Mitotic phenotype Model Reference
RB E2F Chromatin assembly/condensation;
chromosome mis-segregation; impaired
SAC; stabilization of k-MT attachments
Human fibroblasts (WI-38), MEFs,
HCT116, T24, HT1197, SW480,
U2OS, IMR-90, RPE1, NIH-3T3
Ren et al. (2002), Hernando et al.
(2004), Kabeche and Compton
(2012)
RB Chromosome condensation; impaired
centromere structure; heterochromatin
structure; chromosome mis-segregation
MEFs; RPE1; Drosophila
neuroblasts
Isaac et al. (2006), Coschi et al.
(2010), Manning et al. (2010)
RB, p107,
p130
Chromatid breaks; cohesion defects MEFs Manning et al. (2010), van Harn
et al. (2010)
Wnt Conductin/AXIN2
and APC
Premature centrosome separation
(Plk1-dependent); Impaired SAC
(Plk1-dependent)
MEFs; SW480, U2OS, HCT116,
DLD1, HEK293T, HeLa
Hadjihannas et al. (2006),
Hadjihannas et al. (2010), Ruan et al.
(2012)
Disheveled 2
(Dvl2)
Regulation of MT-plus-ends
(Plk1-dependent); Impaired SAC (Mps1,
Bub1, and BubR1-dependent)
HeLaS3, U2OS Kikuchi et al. (2010)
GSK3β Mis-alignment; chromosome
mis-segregation; micronuclei formation
HeLa, HEK293T, Drosophila
embryos
Wakefield et al. (2003), Bobinnec
et al. (2006), Tighe et al. (2007)
β-catenin Loss of centrosome separation;
monopolar spindle formation;
chromosome condensation
HeLa, HEK293T, NIH-3T3, MDCK,
U2OS, DlD1, HCT116
Kaplan et al. (2004), Bahmanyar
et al. (2008), Davalos et al. (2012)
APC Hyper-stabilization of k-MT attachment Mouse ES cells, Ptk2, HT29,
SW480, Caco2, LoVo, HCT116,
RKO, HEK293T, HeLa, RPE1
Fodde et al. (2001), Zumbrunn et al.
(2001), Green and Kaplan (2003),
Green et al. (2005), Draviam et al.
(2006), Bakhoum et al. (2009a)
DNA
damage
p53 Centrosome function (Aurora A, Plk2, and
Plk4-dependent)
Mouse hepatocytes Kurinna et al. (2013)
unknown
component
Centrosome integrity; multipolarity;
chromosome mis-segregation
CHO Hut et al. (2003)
Chk1 k-MT stability (Aurora B-dependent);
Centrosome amplification; Disrupted SAC
function (Mad2, BubR1, and Aurora
B-dependent)
DT40, HCT116, HEK293T, U2OS,
mouse MECs, HC11, NIH-3T3,
HeLa, OVCAR-8, OVCA-432, A2780,
OVCAR-5
Bourke et al. (2007), Zachos et al.
(2007), Carrassa et al. (2009),
Peddibhotla et al. (2009), Chila et al.
(2013)
Chk2/BRCA1 Abnormal mitotic spindle assembly;
lagging chromosomes
HCT116, HeLa, BJ-hTERT Stolz et al. (2010b)
DNA-PKcs Abnormal spindle formation HeLa, AT5BIVA Shang et al. (2010)
Ras HRas Weakened SAC PCCL3 Knauf et al. (2006)
KRas Chromosome mis-segregation DLD1, HCT116 Luo et al. (2009)
BRAF Impaired SAC (Mps1-dependent);
supernumerary centrosomes
SK-MEL-5, SK-MEL-28, A375, SBcl2,
hTERT-HME
Cui et al. (2010)
Notch Notch Mitotic delay (CycB1-dependent) KS-IMM, KS-Y1 Curry et al. (2007)
TGF-β Ski Weakened SAC function; lagging
chromosomes/chromosome bridges;
micronuclei formation
Primary MEFs, SV-40 immortalized
MEFs
Marcelain et al. (2012)
Smad2/3 Impaired SAC function? Sw480, HeLa Zhu et al. (2007)
(Continued)
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Table 1 | Continued
Pathway Gene(s) Mitotic phenotype Model Reference
NF-κB IκB Centrosome function (Aurora
A-dependent); Mitotic arrest (CycB1 and
Plk1-dependent); chromosome
mis-segregation
HeLa, COS7, Primary MEFs Prajapati et al. (2006), Irelan et al.
(2007)
Integrin ILK Centrosome clustering (TACC3 and
ch-TOG-dependent); Hyper-stabilization of
k-MT dynamics
BT549, MDA-MB-231, MCF7,
MCF10A, 184-hTERT, PC3, DU145,
BPH-1, HEK293T, HeLa, IMR-90
Fielding et al. (2008), Fielding et al.
(2011), Lim et al. (2013)
Hippo NDR1/Fry/MST2 Chromosome misalignment HeLa Chiba et al. (2009)
MST1 Centrosome overduplication; Stabilization
of k-MT attachments (Aurora
B-dependent)
HeLa, U2OS, PT67, COS7, RPE1 Hergovich et al. (2009), Oh et al.
(2010)
LATS2 Centrosome fragmentation; chromosome
misalignment; loss of SAC activity;
cytokinesis failure
Primary MEFs Yabuta et al. (2007)
KIBRA Defects in mitotic spindle formation;
chromosome misalignment
HEK293T, MCF7, HeLa Zhang et al. (2012)
study showing that loss of pRB, p107, and p130 in mouse embry-
onic fibroblasts (MEFs) causes a G2 arrest coupled with DNA
damage which results in chromatid breaks and cohesion defects
in mitotic chromosomes (van Harn et al., 2010). Finally, Manning
and co-workers demonstrated that pRB depletion alters the cen-
tromeric localization of CAP-D3/condensin II, leading to distorted
centromere structure and increased inter-kinetochore distance.
These centromere distortions increase the propensity of merotelic
k-MT attachment leading to CIN (Manning et al., 2010). Taken
together, these studies show that in addition to altered cell cycle
regulation, the loss of pRB alters centromere geometry to increase
the rate of formation of k-MT attachment errors and hyper-
stabilizes k-MTs to reduce the rate of correction of attachment
errors (Hernando et al., 2004; Isaac et al., 2006; Manning et al.,
2010; van Harn et al., 2010).
THE WNT SIGNALING PATHWAY
The Wnt signaling pathway plays a critical role in stem cell renewal,
survival, and differentiation, as well as in the normal development
and homeostasis of tissues including the mammary gland (Boras-
Granic and Wysolmerski, 2008). De-regulation of Wnt signaling
plays a causal role in breast cancer (reviewed in Prosperi and Goss,
2010). Aberrant Wnt signaling has been shown to play role in accel-
erating tumorigenesis by promoting CIN in the absence of p53
(Donehower et al., 1995) and numerous studies have implied that
Wnt signaling is directly involved in mitotic regulation (reviewed
in Niehrs and Acebron, 2012).
Excessive Wnt signaling up-regulates expression of con-
ductin/AXIN2, a protein involved in SAC signaling and cen-
trosome cohesion (Hadjihannas and Behrens, 2006; Hadjihan-
nas et al., 2010). Conductin localizes to mitotic spindles and
high conductin expression attenuates SAC activity via a Polo-
like kinase 1 (Plk1)-dependent mechanism (Hadjihannas et al.,
2006). Additionally, Axin phosphorylation by Plk1 is essential for
proper centrosome function (Ruan et al., 2012). Plk1 also phos-
phorylates Disheveled 2 (Dvl2), a central component of the Wnt
signaling pathway that plays a role in SAC activation by recruit-
ing SAC components Mps1, Bub1, and BubR1 to kinetochores
(Kikuchi et al., 2010). In addition to conductin and Dvl2, both
GSK3β and β-catenin have been shown to be involved in cen-
trosome separation and to regulate spindle microtubules during
mitosis (Wakefield et al., 2003; Kaplan et al., 2004; Bobinnec et al.,
2006; Bahmanyar et al., 2008). Consistently, treating human cells
with GSK3β-inhibitors was shown to induce CIN (Tighe et al.,
2007). Wnt signaling also regulates mitosis through the con-
served protein Adenomatous Polyposis Coli (APC). APC enhances
the correction of k-MT attachment errors because truncation or
depletion of APC in human cells increases k-MT stability through
interactions with microtubule plus-ends and induces chromo-
some mis-segregation (Fodde et al., 2001; Zumbrunn et al., 2001;
Green and Kaplan, 2003; Green et al., 2005; Draviam et al., 2006;
Bakhoum et al., 2009a). However, since APC is commonly mutated
and/or truncated in tumor cells, the role of APC in regulating
microtubule plus-ends is most likely independent of Wnt signal-
ing. Finally, SMC2, a core subunit of the condensin complex, is a
transcriptional target of the Wnt signaling pathway demonstrating
a functional link between Wnt signaling and chromosome conden-
sation (Davalos et al., 2012). These results suggest that excessive
Wnt signaling decreases the efficiency of the correction of k-MT
attachment errors and increases the rate of formation of k-MT
attachment errors by stabilizing k-MT attachments, influencing
centrosome cohesion, and affecting centromere geometry.
THE RAS SIGNALING PATHWAY
The Ras oncogene is one of the most commonly mutated genes
across an array of cancer types and de-regulated signaling through
receptor-tyrosine kinase pathways caused by mutant Ras (or its
GAP or GEF) affects cell cycle regulation, apoptosis, and cell
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survival (reviewed in Malumbres and Barbacid, 2003). Apart
from the well-characterized roles that Ras signaling plays in cell
cycle progression, it has also been implicated in the mainte-
nance of genome integrity and this hypothesis gains strength
with several important observations (reviewed in Kamata and
Pritchard, 2011). First, cells harboring gain-of-function Ras muta-
tions exhibit changes in DNA ploidy and genomic rearrangements
in mouse models and rat cells (Ichikawa et al., 1990; Denko et al.,
1994; Saavedra et al., 2000; Baker et al., 2013). Consistently, onco-
genic HRasG12V expression in rat thyroid cells was shown to
weaken the SAC response to microtubule targeting drugs (Knauf
et al., 2006). Furthermore, expression of oncogenic Ras at endoge-
nous levels is sufficient to generate chromosome mis-segregation
in cancer cells perhaps through Plk1 and the Anaphase-Promoting
Complex/Cyclosome (APC/C) (Luo et al., 2009). Importantly, an
elegant set of experiments using primary MEFs grown under con-
ditions that preserve diploid karyotypes showed that expression of
HRasG12V resulted in the induction of CIN, an outcome that was
enhanced by the absence of p53 (Woo and Poon, 2004).
The ERK pathway is the best-characterized signaling pathway
downstream of Ras and its contribution to mitotic progression
in human cells appears to be cell-type dependent. For exam-
ple, depletion of ERK1/2 in keratinocytes, but not in fibroblasts,
induces a CyclinB1-dependent G2/M arrest (Dumesic et al., 2009).
Additionally, ERK1/2 has been detected at centrosomes and kine-
tochores during mitosis (Shapiro et al., 1998; Lou et al., 2004) but a
functional role for ERKs during mitosis has so far remained elusive.
Furthermore, another downstream target of Ras is Raf kinase, and
human melanoma cells expressing oncogenic B-RAFV600E were
shown to “hyperactivate” the SAC through stabilization of Mps1
and induce supernumerary centrosomes resulting in chromosome
mis-segregation accompanied by aneuploidy (Cui et al., 2010).
These reports provide evidence that deranged Ras signaling can
induce CIN although the precise molecular mechanism leading to
elevated chromosome mis-segregation remain elusive.
THE TRANSFORMING GROWTH FACTOR BETA (TGF-β)
SIGNALING PATHWAY
TGF-β signaling is involved in the regulation of cell proliferation,
differentiation, motility, adhesion, and apoptosis and therefore
de-regulation of the TGF-β pathway is thought to play a criti-
cal function in cancer development. However, the role of TGF-β
signaling in tumorigenesis is somewhat paradoxical since it acts as
a tumor suppressor at early stages of cancer development and as an
oncogene at terminal stages of the disease by initiating a transcrip-
tional program required for the activation of genes involved in cell
metastasis and invasion (reviewed in Massague, 2008; Barcellos-
Hoff and Akhurst, 2009; Padua and Massague, 2009). The primary
intracellular mediators of TGF-β are the Smad proteins, which are
phosphorylated and activated by the TGF-β Receptor I (TβRI)
kinase. This phosphorylation event promotes translocation of
Smad proteins to the nucleus where they cooperate with tran-
scription factors to regulate gene expression (Derynck and Zhang,
2003).
The link between TGF-β signaling and mitosis came from the
observation that endogenous Smads bind microtubules and that
microtubule-depolymerization in cells triggers phosphorylation
of Smad2 (Dong et al., 2000). Subsequently, it was shown
that the conserved SAC protein Mps1 co-purifies with the
Smad protein complex and that nocodazole treatment results
in Mps1-dependent phosphorylation and consequent activation
of Smad2/3 proteins (Zhu et al., 2007). Interestingly, regulation
of Smad3 phosphorylation in mitosis was not only dependent
on Mps1, but also on ERK activation (Hirschhorn et al., 2012).
This raises the possibility of cross-talk between TGF-β activa-
tion and Ras signaling in mitosis. Another link between TGF-β
signaling and mitosis involves the transcriptional co-activator pro-
tein Ski, which acts as a negative regulator of TGF-β signaling.
Ski protein levels peak during mitosis and immunofluorescence
imaging of U2OS cells demonstrates that Ski localizes at centro-
somes and mitotic spindles (Marcelain and Hayman, 2005) and is
directly phosphorylated by Aurora A in vitro (Mosquera et al.,
2011). The functional significance of this localization became
clear through a study demonstrating that Ski−/− MEFs have a
weakened SAC and show increased rates of lagging chromosomes
during anaphase resulting in micronuclei formation and the gen-
eration of aneuploidy and CIN (Marcelain et al., 2012). Thus,
the activities of Smads and Ski show that alterations in TGF-
β signaling disrupt chromosome segregation during mitosis to
promote CIN.
THE NUCLEAR FACTOR KAPPA-LIGHT-CHAIN ENHANCER OF
ACTIVATED B CELLS (NF-κB) PATHWAY
The connection between inflammation and cancer was described
several decades ago and this connection has been strengthened by
the identification of constitutively active NF-κB signaling in many
cancer types (Karin and Greten, 2005; Maeda and Omata, 2008).
Induction of this pathway by specific stimuli leads to phospho-
rylation of the IκB complex resulting in its targeted destruction
and activation of NF-κB. NF-κB is then imported in the nucleus
where it activates transcription of target genes involved in immune
responses and inflammation.
The IκB complex is composed of two catalytic kinase subunits:
IKKα and IKKβ and both kinases have been shown to play dis-
tinct roles in mitotic fidelity. Depletion of IKKα in HeLa cells
induces a mitotic arrest caused by increased Cyclin B and Plk1.
IKKα was also shown to directly phosphorylate and modulate
Aurora A kinase activity at centrosomes (Prajapati et al., 2006).
These effects appear to be IKKβ-independent, however perturba-
tion of IKKβ in HeLa cells promotes multipolar spindle formation,
chromosome mis-segregation and de-regulation of Aurora A sta-
bility. This suggests that disruption of IKKα and IKKβ converge
on Aurora A kinase (Irelan et al., 2007).
Additional involvement of this pathway in mitosis is through
signal adapter proteins. The signaling adaptor p62 is necessary
for Ras to trigger IκB and consequently activate the NF-κB path-
way. It has also been implicated in mitotic regulation (Moscat and
Diaz-Meco, 2012). A recent report demonstrated that Cdk1 phos-
phorylates p62 to regulate Cyclin B levels during mitosis suggesting
that p62 may play a role in SAC maintenance (Linares et al., 2011).
Importantly, the authors demonstrate that expression of a non-
phosphorylatable p62 increases lagging chromosome rates during
anaphase and induces micronuclei formation, features which are
consistent with the induction of CIN.
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INTEGRIN SIGNALING AND CELL ADHESION
One important characteristic of transformed cells is their ability to
grow in an anchorage-independent fashion and this feature of can-
cer cells has led to the suggestion that Integrin signaling may play
an important role in tumorigenesis. Integrin signaling is thought
to couple proliferation and survival signaling with anchorage-
dependent growth. De-regulated Integrin signaling is thought
to provide a metastatic advantage for tumor cells (reviewed in
Giancotti and Ruoslahti, 1999).
A key regulator of Integrin signaling is Integrin-linked kinase
(ILK). ILK was identified as an interactor of β1- and β3-integrin
subunits which localizes to both focal adhesions and centrosomes
and the cellular functions of ILK include cytoskeleton organiza-
tion, cell adhesion, and migration (reviewed in Hannigan et al.,
2011). ILK levels have been found to be elevated in many can-
cer types and correlated to poor patient prognosis (McDonald
et al., 2008). Recently, ILK was reported to play an important role
in centrosome clustering in cancer cell lines by modulating the
microtubule associated proteins TACC3 and ch-TOG (Fielding
et al., 2008, 2011). Centrosome de-clustering induces chromo-
some mis-segregation providing a role for ILKs in mitosis. A
more recent study demonstrated that pharmacological inhibition
of ILK causes hyper-stabilization of k-MT dynamics resulting in
increased centromeric tension in aligned chromosomes (Lim et al.,
2013). Stabilization of k-MT attachments is a proven mechanism
of CIN in cancer cells (Bakhoum et al., 2009a,b) indicating that ILK
is involved in the regulation of proper chromosome segregation
and may contribute to CIN.
THE HIPPO SIGNALING PATHWAY
The Hippo pathway was originally identified in Drosophila and
is conserved in mammals. This pathway is responsible for coordi-
nating cell proliferation and apoptosis to govern mechanisms of
cell contact inhibition, organ size control, and cancer progression
(reviewed in Saucedo and Edgar, 2007). In agreement, this path-
way contains both oncogenes and tumor suppressor genes whose
homologs have been identified in mammals (Overholtzer et al.,
2006; Zender et al., 2006; Harvey and Tapon, 2007).
The first clue that the Hippo signaling pathway could be directly
contributing to mitotic progression came from a study report-
ing that the activity of MST1 and MST2, two essential kinases of
the Hippo pathway in mammalian cells, increases during mitosis,
and that this effect was enhanced by microtubule-depolymerizing
drugs (Praskova et al., 2008). A subsequent study reported that
depletion of NDR1, a downstream target of MST kinases, causes
MST2-dependent mitotic chromosome misalignment in HeLa
cells (Chiba et al., 2009). Independently, NDR phosphorylation
by MST1 was also demonstrated to play an important role in
the control of centrosome duplication (Hergovich et al., 2009).
Similarly to MST2, MST1 was also reported to participate in chro-
mosome alignment by directly phosphorylating Aurora B to limit
its kinase activity and promote stable k-MT attachments during
mitosis, demonstrating a functional link between Hippo signal-
ing and the correction of k-MT attachment errors (Oh et al.,
2010).
Another link between the Hippo pathway and mitosis is
through the large tumor suppressor 2 (Lats2). Lats2 is a kinase
involved in Hippo signaling which has been shown to inhibit Cdk1
activity in HeLa cells (Kamikubo et al., 2003). Interestingly, Lats2-
deficient MEFs show severe mitotic defects including centrosome
fragmentation, chromosome misalignment, loss of SAC activity,
and consequent cytokinesis failure (Yabuta et al., 2007). Further-
more, Lats2 localizes to centrosomes in mitosis and its localization
is dependent on phosphorylation by Aurora A (Toji et al., 2004).
Finally, the WW domain-containing protein KIBRA (enriched in
KIdney and BRAin) was recently identified as a novel regulator
of the Hippo pathway and was shown to be phosphorylated by
Aurora A, Aurora B (Xiao et al., 2011b), and Lats2 (Xiao et al.,
2011a). It was subsequently shown that depletion of KIBRA causes
defects in mitotic spindle formation and chromosome alignment
suggesting that it is an active player in mitotic fidelity (Zhang et al.,
2012). Collectively, these reports show strong evidence that Hippo
signaling plays an important role in generating CIN by affect-
ing faithful chromosome segregation during mitosis although
many of the molecular mechanisms involving Lats2 and KIBRA in
chromosome segregation are currently unclear.
THE DNA DAMAGE RESPONSE
The DNA damage checkpoint is a conserved molecular mechanism
essential for DNA repair and has been commonly associated with
the maintenance of genome stability and carcinogenesis (Hoei-
jmakers, 2001). Intriguingly, this checkpoint responds to DNA
damage throughout the cell cycle, except in mitosis. The role
of the DNA damage pathway in affecting mitotic fidelity is cur-
rently a topic of intense investigation (reviewed in Hayashi and
Karlseder, 2013). One area focuses on the role of p53, which
in principle contributes to CIN through two mechanisms. One
relates to how the DNA damage pathway responds to chromosome
mis-segregation. Loss of p53 function has been shown to provide
tolerance for aneuploidy and further propagation of those ane-
uploid cells can induce CIN (Bunz et al., 2002; Thompson and
Compton, 2010). The second relates to how p53 regulates expres-
sion of genes that encode proteins involved in mitosis such as
Aurora A, Plk2, and Plk4 (Kurinna et al., 2013). The stabilization
of p53 in response to DNA damage increases the expression of
these genes hinting at a more direct role in disrupting faithful
chromosome segregation.
Numerous studies have implicated DNA damage pathway com-
ponents other than p53 in the induction of CIN by tampering with
the fidelity of chromosome segregation during mitosis. In mam-
malian cells, centrosome integrity was shown to be affected upon
DNA damage, resulting in multipolarity and consequent chromo-
some mis-segregation (Hut et al., 2003). Chk1, a component of the
DNA damage and replication checkpoints, has been directly impli-
cated in mitotic regulation through several independent mech-
anisms. First, it is required for centrosome amplification upon
DNA damage (Bourke et al., 2007). Second, it participates in the
k-MT error correction machinery by directly phosphorylating and
enhancing Aurora B activity in vitro (Zachos et al., 2007). Third,
Chk1 depletion in human osteosarcoma cells disrupts the SAC
by affecting Mad2 and BubR1 levels and consequently increases
the rate of chromosome mis-segregation (Carrassa et al., 2009;
Peddibhotla et al., 2009). Finally, a recent report has demon-
strated that apart from its role in phosphorylating Aurora B,
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Chk1 also directly phosphorylates SAC component Mad2 sug-
gesting multiple levels of mitotic regulation by Chk1 (Chila et al.,
2013).
Depletion of Chk2 or abrogation of its kinase activity was
shown to cause mitotic delay, promote the generation of lag-
ging chromosomes and consequently induce CIN through a
BRCA1-dependent but p53-independent mechanism (Stolz et al.,
2010a,b). Importantly, these reports demonstrate that the DNA
damage pathway combines tumor-suppressive properties with
the maintenance of chromosome integrity (Sato et al., 2010).
Chk2, together with Plk1, Cdk1, and 53BP1 (p53-binding protein-
1) was also postulated to participate in a mitotic phosphory-
lation feedback network responsible for inactivating the G2/M
DNA damage checkpoint (van Vugt et al., 2010). In budding
yeast, the Chk2 homolog Rad53, also plays an important role
in suppressing the cleavage of sister chromatid cohesion and
spindle elongation to preserve genomic stability (Zhang et al.,
2009).
In addition, DNA-dependent protein kinase catalytic sub-
units (DNA-PKcs), known for their active role in DNA non-
homologous end joining (NHEJ), have also been shown to localize
to centrosomes, kinetochores, and the midbody (Shang et al.,
2010). However, the role that DNA-PKcs play in mitotic fidelity is
currently unclear. Importantly, more than 50% of all cancers carry
mutations in components of the DNA damage pathway (Holl-
stein et al., 1991) and these lines of evidence strongly point to
the participation of this pathway in the formation or correction
of k-MT attachment errors which are known to be a common
cause of CIN.
Despite the compelling evidence that CIN is caused by defective
chromosome segregation in mitosis (Cimini et al., 2001; Loncarek
et al., 2007; Thompson and Compton, 2008; Bakhoum et al., 2009a;
Ganem et al., 2009; Silkworth et al., 2009; Manning et al., 2010;
Thompson et al., 2010; Nicholson and Cimini, 2011; Schvartz-
man et al., 2011; Hood et al., 2012; Kabeche and Compton, 2012;
Vitre and Cleveland, 2012), a recent report suggests that CIN is
caused by pre-mitotic events induced by replication stress (Bur-
rell et al., 2013). The authors state that most anaphase defects
arise through pre-mitotic defects suggesting that activation of
DNA damage through replication stress reflects a cause, rather
than a consequence, of segregation errors (Burrell et al., 2013).
The expected outcome of replication stress is chromosome frag-
ments, including those that are acentric, which was documented
in that work. So, that is not surprising. However, the surprise is
the proposition that replication stress causes whole chromosome
mis-segregation through a mechanism independent of defects of
the segregation process in mitosis. DNA replication stress has been
observed across several tumor types (Dereli-Oz et al., 2011) and
the recent results illustrate a need to search for the mechanism
that causes whole chromosome mis-segregation as a consequence
of replication stress.
Interestingly, recent work has shown that chromosome seg-
regation defects can lead to DNA damage. For example, it was
shown that lagging chromosomes in anaphase tend to be trapped
in the cytokinetic furrow resulting in DNA double strand breaks
(Hoffelder et al., 2004; Janssen et al., 2011). Also, lagging chro-
mosomes tend to form micronuclei in the subsequent G1 phase.
The chromosomes trapped in micronuclei do not replicate on
time with the major nucleus and are occasionally pulverized
in the subsequent mitosis (Crasta et al., 2012). These results
reveal a potentially vicious cycle. Chromosome segregation errors
lead to DNA damage and that damage may promote further
chromosome mis-segregation. Analyzing the link between onco-
genic signaling and DNA replication might therefore provide
important clues regarding the induction of CIN via pre-mitotic
events.
SIGNALING PATHWAY CROSS-TALK
This summary provides convincing evidence for the role of com-
monly mutated oncogenic signaling pathways in cancer for the
induction of CIN. This summary has specifically treated each sig-
naling pathway as an independent linear entity. However, in actual-
ity, there is extensive interconnection between signaling pathways
leading to cell-, tissue-, and cancer-type specificity in effects and
outcomes of pathway activation. In particular, the specific exper-
imental conditions used to test the role of a signaling pathway
could impose a great degree of variability on the results generated
and interpretations need to be made carefully based upon the cell,
tissue, or cancer model system being employed.
For example, Notch signaling was first linked to tumorigenesis
through the identification of a frequent chromosomal translo-
cation found in a subset of human T-cell acute lymphoblastic
leukemias (T-ALL) (Ellisen et al., 1991). It has since been shown
to be involved in several tumor types (reviewed in Allenspach
et al., 2002). Interestingly, Notch can behave as both a dominant
oncoprotein and as a tumor suppressor which is not surprising
given the diversity of Notch functions reported to date (Lobry
et al., 2011). Although Notch mutations have been associated with
poor patient prognosis, no clear connections to CIN have thus
far been established. However, Notch signaling is connected to
most other signaling pathways. Expression of Wnt activates Notch
signaling in human mammary epithelial cells and this link has
been confirmed in a panel of 34 breast carcinomas suggesting
that there is a need for Notch-Wnt cross-talk during mammary
tumorigenesis (Ayyanan et al., 2006). TGF-β signaling has also
been demonstrated to up-regulate Notch in multiple types of
mammalian cells and both TGF-β and Notch can synergistically
regulate the same target genes in many cell types (Blokzijl et al.,
2003). Notch ligand JAG2 is induced by Hedgehog signaling dur-
ing carcinogenesis (Katoh, 2007) and the cross-talk between Ras
and Notch pathways has been amply documented in several tumor
types including adenocarcinomas, gliomas, leukemias, and breast
cancers (Chiang et al., 2008; Kindler et al., 2008; Mittal et al.,
2009; Hanlon et al., 2010; Xu et al., 2010). Aberrant Notch signal-
ing can also increase NF-κB activity by directly interacting with
NF-κB and promoting its nuclear retention (Shin et al., 2006).
Furthermore, upstream regulators have been shown to combine
the promotion of constitutive Notch signaling with an attenua-
tion of the DNA damage pathway (Colaluca et al., 2008) providing
evidence to suggest that activation of these pathways via differ-
ent stimuli may differentially affect how these pathways operate.
Thus, Notch signaling may be an important conspirator with these
other signaling pathways to affect cell cycle regulation and/or
induce CIN.
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Many of these signaling pathways also interconnect with the
DNA damage response. For example, the RB pathway has also
been shown to cooperate with TGF-β signaling in the context of
mammary gland development (Francis et al., 2009) and a mol-
ecular link between RB signaling, the DNA damage checkpoint
and the SAC has recently been reported (Jahn et al., 2013). Cross-
talk between the DNA damage pathway and the Hippo pathway
via LATS2 has also been established in liver cells (Kurinna et al.,
2013). In addition, NF-κB signaling has been shown to cooperate
with Ras signaling through the adaptor protein p62 (Linares et al.,
2011).
Since cross-talk between pathways is dependent upon intri-
cate feedback loops and intersections at critical nodes that ensure
cellular homeostasis it is important to understand the cell-, tissue-
, and cancer-specific context in how these pathways interact.
For example, during breast cancer progression, TGF-β represses
NF-κB in normal cells but activates NF-κB in malignant coun-
terparts (Neil and Schiemann, 2008). A cautionary note is that
many of the results summarized here were obtained using can-
cer cell lines in which the genetic background is often unknown
which may confound clear interpretation. The interconnectedness
of cell signaling circuitry adds a layer of complexity that chal-
lenges our understanding of how signaling pathways not only drive
tumorigenesis but induce CIN.
CONCLUSION
The oncogenic signaling pathways described here all play dual
roles. They act as drivers for tumorigenesis and they induce CIN.
This connection to CIN arises because they disrupt the careful
orchestration of events required for accurate chromosome seg-
regation during mitosis by decreasing the rate of correction of
k-MT attachment errors and/or increasing the rate of formation
of those errors through extra centrosomes or disruption of cen-
tromere geometry. The notion that tumor suppressor genes (and,
by extension, oncogenes) combine their known roles in cell cycle
progression, growth, and differentiation with the induction of
genomic instability is not necessarily new and a substantial body
of evidence supports this (reviewed in Coschi and Dick, 2012).
The central point we are making here is that the molecular con-
nections between these signaling pathways and CIN are becoming
clearer as insights into the underlying mechanisms generating CIN
are married to our understanding of these signaling pathways.
Collectively, these reports demonstrate that there is tight com-
munication between mitosis and oncogenic signaling suggesting
that mutations leading to mis-regulation of oncogenic pathways
not only cause aberrant cell cycle regulation, but also modulate
mitosis to generate CIN.
The integration of oncogenic signaling pathways with the
induction of CIN changes the way we think about these processes.
They can no longer be considered as separate cancer-associated
insults. The persistent chromosome mis-segregation in CIN can-
cer cells provides an agent of genomic change that permits new
phenotypes to emerge such as resistance to the toxicity imposed
by chemotherapeutic agents. As such, the oncogenic signaling
pathways that combine the promotion of cell cycle progression
with the induction of CIN may be the most difficult to treat
offering some insight into the correlation of CIN and poor
patient prognosis. The unanswered question is whether the tar-
geted inhibition of the cancer driving signaling pathway would
also rob the cancer cell of its ability to adapt through CIN. Or,
once initiated, does CIN become a self-sustaining process that
can’t be reversed even if the activity from the oncogenic path-
way that started it is quelled? Also, why have signaling pathways
evolved these dual roles to influence mitotic events? Is their role
in mitosis a part of their normal function that becomes exag-
gerated upon oncogenic activation or is their mitotic role an
off-target effect resulting from a dereliction of function after
oncogenic activation? Understandably, these dual roles may be
of particular value for stable diploid cells where it is impor-
tant to stall cell cycle progression following chromosome mis-
segregation. However, in the context of tumorigenesis this may
turn out to be a double-edged sword that combines de-regulated
cell cycle progression with the disruption of mitosis to gen-
erate the highly complex karyotypes typical of solid tumors.
Our understanding of the links between oncogenic pathways
and CIN provide the tools to begin to answer these important
questions.
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